CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to revolutionize drug manufacturing by using inkjet printing technology to create personalized medication dosages. It focuses on delivering precise amounts of levothyroxine for hypothyroidism on porous tablets, paving the way for individualized treatments that reduce waste and enhance patient care.
Methods of pharmaceutical manufacturing are likely to change dramatically over the coming years.
Driven by the knowledge and technology that is already available in other sectors, the processing of drugs into dosage units can be transformed into a “pharmacy-on-demand” process that allows individual dosing, based on criteria relevant for the effective use of the drug in an individual patient.
One approach to achieve “pharmacy-on-demand” is the use of inkjet printing technology to deliver an exact…
UNIVERSITY OF STUTTGART
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
